Cargando…

Drug combination therapy for emerging viral diseases

Effective therapeutics to combat emerging viral infections are an unmet need. Historically, treatments for chronic viral infections with single drugs have not been successful, as exemplified by human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections. Combination therapy for these d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shyr, Zeenat A., Cheng, Yu-Shan, Lo, Donald C., Zheng, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd. 2021
Materias:	Post-Screen (Grey)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139175/ https://www.ncbi.nlm.nih.gov/pubmed/34023496 http://dx.doi.org/10.1016/j.drudis.2021.05.008

Ejemplares similares

Repurposing drugs as COVID-19 therapies: A toxicity evaluation
por: Ngan, Deborah K., et al.
Publicado: (2022)

High‐throughput screening assays for SARS‐CoV‐2 drug development: Current status and future directions
por: Xu, Tuan, et al.
Publicado: (2021)

Nucleosides and emerging viruses: A new story
por: Roy, Vincent, et al.
Publicado: (2022)

Drug repurposing against SARS-CoV-2 using computational approaches
por: Kumar, Sumit, et al.
Publicado: (2022)

Selection of data sets for FAIRification in drug discovery and development: Which, why, and how?
por: Alharbi, Ebtisam, et al.
Publicado: (2022)

Integrating heterogeneous data to facilitate COVID-19 drug repurposing
por: Prieto Santamaría, Lucía, et al.
Publicado: (2022)

Efficacy of repurposed antiviral drugs: Lessons from COVID-19
por: Martinez, Miguel Angel
Publicado: (2022)

Exploiting protease activation for therapy
por: Bleuez, Chloe, et al.
Publicado: (2022)

Myotonic dystrophy type 1 drug development: A pipeline toward the market
por: Pascual-Gilabert, Marta, et al.
Publicado: (2021)

Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2
por: Ho, Gilbert, et al.
Publicado: (2021)

The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19
por: Basile, Maria Sofia, et al.
Publicado: (2022)

Recent progress on rapid SARS-CoV-2/COVID-19 detection by CRISPR-Cas13-based platforms
por: Aquino-Jarquin, Guillermo
Publicado: (2021)

The current status of COVID-19 vaccines. A scoping review
por: Rueda-Fernández, Manuel, et al.
Publicado: (2022)

Nanosponges: An overlooked promising strategy to combat SARS-CoV-2
por: Mostafavi, Ebrahim, et al.
Publicado: (2022)

How to build a tumor: An industry perspective
por: Schueler, Julia, et al.
Publicado: (2022)

COVID-19 and fibrosis: Mechanisms, clinical relevance, and future perspectives
por: Saifi, Mohd Aslam, et al.
Publicado: (2022)

Nanomedicine approaches to reduce cytokine storms in severe infections
por: Ahmar Rauf, Mohd, et al.
Publicado: (2022)

Impact of COVID-19 on male urogenital health: Success of vaccines
por: Kucukyildiz, Kutay, et al.
Publicado: (2022)

Steps toward nebulization in-use studies to understand the stability of new biological entities
por: Montefusco-Pereira, Carlos Victor
Publicado: (2023)

Harnessing aptamers against COVID-19: A therapeutic strategy
por: Mahmoudi, Ali, et al.
Publicado: (2023)

Viral Proteases as Targets for Coronavirus Disease 2019 Drug Development
por: Zhu, Wei, et al.
Publicado: (2021)

A de novo missense mutation of GABRB2 causes early myoclonic encephalopathy
por: Ishii, Atsushi, et al.
Publicado: (2017)

Providing recurrence risk counselling for parents after diagnosis of a serious genetic condition caused by an apparently de novo mutation in their child: a qualitative investigation of the PREGCARE strategy with UK clinical genetics practitioners
por: Kay, Alison C, et al.
Publicado: (2023)

Swiss cost-effectiveness analysis of universal screening for Lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives
por: Salikhanov, Islam, et al.
Publicado: (2022)

Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing
por: Kenna, Kevin P, et al.
Publicado: (2013)

Canadian Open Genetics Repository (COGR): a unified clinical genomics database as a community resource for standardising and sharing genetic interpretations
por: Lerner-Ellis, Jordan, et al.
Publicado: (2015)

Can a print‐based intervention increase screening for first degree relatives of people with colorectal cancer? A randomised controlled trial
por: Carey, Mariko, et al.
Publicado: (2016)

Risk category system to identify pituitary adenoma patients with AIP mutations
por: Caimari, Francisca, et al.
Publicado: (2018)

Developing better strategies for school eye health screening in India
por: Reddy, Priya Adhisesha, et al.
Publicado: (2017)

Screening for ROP
por: Quinn, Graham, et al.
Publicado: (2017)

Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies
por: Niedermaier, Tobias, et al.
Publicado: (2018)

A systematic review of health promotion interventions to increase breast cancer screening uptake: from the last 12 years
por: Agide, Feleke Doyore, et al.
Publicado: (2018)

Moving towards an organized cervical cancer screening: costs and impact
por: Diaz, Mireia, et al.
Publicado: (2018)

Effects of screening and universal healthcare on long-term colorectal cancer mortality
por: Lee, Yi-Chia, et al.
Publicado: (2019)

Association of ten gastrointestinal and other medical conditions with positivity to faecal occult blood testing in routine screening: a large prospective study of women in England
por: He, Emily, et al.
Publicado: (2019)

Number of prior negative screening outcomes does not influence future risk of breast cancer
por: Lilleborge, Marie, et al.
Publicado: (2020)

Genetic screening for monogenic hypertension in hypertensive individuals in a clinical setting
por: Bao, Minghui, et al.
Publicado: (2020)

Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data
por: Hüsing, Anika, et al.
Publicado: (2020)

Screening for caregiver psychosocial risk in children with medical complexity: a cross-sectional study
por: Verma, Rahul, et al.
Publicado: (2020)

Targeting lung cancer screening to individuals at greatest risk: the role of genetic factors
por: Lebrett, Mikey B, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7gq8b6jm5mhvjul50r0ai2pfp1